249 related articles for article (PubMed ID: 7589072)
61. Immune privilege in the anterior chamber of the eye: alloantigens and tumour-specific antigens presented into the anterior chamber simultaneously induce suppression and activation of delayed hypersensitivity to the respective antigens.
Benson JL; Niederkorn JY
Immunology; 1992 Oct; 77(2):189-95. PubMed ID: 1427974
[TBL] [Abstract][Full Text] [Related]
62. Eye-mediated induction of specific immune tolerance to encephalitogenic antigens.
Farooq SM; Ashour HM
CNS Neurosci Ther; 2013 Jul; 19(7):503-10. PubMed ID: 23522052
[TBL] [Abstract][Full Text] [Related]
63. Indoleamine 2,3-dioxygenase (IDO) is involved in promoting the development of anterior chamber-associated immune deviation.
Chen X; Liu L; Yang P; Wu C; Jin H; Xing L; Li B; Zhou H; Huang X; Zhu L
Immunol Lett; 2006 Nov; 107(2):140-7. PubMed ID: 17055065
[TBL] [Abstract][Full Text] [Related]
64. Thymocytes induced by antigen injection into the anterior chamber activate splenic CD8+ suppressor cells and enhance the antigen-induced production of immunoglobulin G1 antibodies.
Li X; Wang Y; Urso D; O'Rourke J; Cone RE
Immunology; 2004 Sep; 113(1):44-56. PubMed ID: 15312135
[TBL] [Abstract][Full Text] [Related]
65. The in vivo and in vitro induction of anterior chamber associated immune deviation to myelin antigens in C57BL/6 mice.
Farooq SM; Elkhatib WF; Ashour HM
Brain Behav Immun; 2014 Nov; 42():118-22. PubMed ID: 24953428
[TBL] [Abstract][Full Text] [Related]
66. Immune privilege in the anterior chamber of the eye is not extended to intraocular Listeria monocytogenes.
Li XY; Niederkorn JY
Ocul Immunol Inflamm; 1997 Dec; 5(4):245-57. PubMed ID: 9455741
[TBL] [Abstract][Full Text] [Related]
67. Exogenous recombinant interleukin-2 abrogates anterior-chamber-associated immune deviation.
Niederkorn JY
Transplantation; 1987 Apr; 43(4):523-8. PubMed ID: 2953091
[TBL] [Abstract][Full Text] [Related]
68. [The influence of glaucoma filtration surgery on anterior chamber associated immune deviation in mice].
Xu JJ; Sun XH
Zhonghua Yan Ke Za Zhi; 2009 Jan; 45(1):32-7. PubMed ID: 19484928
[TBL] [Abstract][Full Text] [Related]
69. The presence of donor-derived class II-positive cells abolishes immune privilege in the anterior chamber of the eye.
Benson JL; Niederkorn JY
Transplantation; 1991 Apr; 51(4):834-8. PubMed ID: 2014538
[TBL] [Abstract][Full Text] [Related]
70. gammadelta T cells are critical for the induction of anterior chamber-associated immune deviation.
Xu Y; Kapp JA
Immunology; 2001 Oct; 104(2):142-8. PubMed ID: 11683953
[TBL] [Abstract][Full Text] [Related]
71. Role of IFN-γ in the establishment of anterior chamber-associated immune deviation (ACAID)-induced CD8+ T regulatory cells.
Paunicka K; Chen PW; Niederkorn JY
J Leukoc Biol; 2012 Mar; 91(3):475-83. PubMed ID: 22180630
[TBL] [Abstract][Full Text] [Related]
72. Alloantigens introduced into the anterior chamber of the eye induce systemic suppression of delayed hypersensitivity to third-party alloantigens through "linked recognition".
Niederkorn JY; Mayhew E; He Y
Transplantation; 1995 Aug; 60(4):348-54. PubMed ID: 7652764
[TBL] [Abstract][Full Text] [Related]
73. CD4+CD25+Tregs express an increased LAG-3 and CTLA-4 in anterior chamber-associated immune deviation.
Zhu X; Yang P; Zhou H; Li B; Huang X; Meng Q; Wang L; Kijlstra A
Graefes Arch Clin Exp Ophthalmol; 2007 Oct; 245(10):1549-57. PubMed ID: 17541623
[TBL] [Abstract][Full Text] [Related]
74. CD25+, interleukin-10-producing CD4+ T cells are required for suppressor cell production and immune privilege in the anterior chamber of the eye.
Skelsey ME; Mayhew E; Niederkorn JY
Immunology; 2003 Sep; 110(1):18-29. PubMed ID: 12941137
[TBL] [Abstract][Full Text] [Related]
75. Th1/Th2-balance in anterior chamber-associated immune deviation by alloantigen.
Sakai R; Yamagami S; Inoki T; Tsuru T; Kawashima H
Graefes Arch Clin Exp Ophthalmol; 2002 Feb; 240(2):154-9. PubMed ID: 11931082
[TBL] [Abstract][Full Text] [Related]
76. Eye-mediated immune tolerance to Type II collagen in arthritis-prone strains of mice.
Farooq SM; Kumar A; Ashour HM
J Cell Mol Med; 2014 Dec; 18(12):2512-8. PubMed ID: 25211510
[TBL] [Abstract][Full Text] [Related]
77. Ocular immune privilege and CD1d-reactive natural killer T cells.
Sonoda KH; Stein-Streilein J
Cornea; 2002 Mar; 21(2 Suppl 1):S33-8. PubMed ID: 11995808
[TBL] [Abstract][Full Text] [Related]
78. Effect of local macrophage depletion on cellular immunity and tolerance evoked by corneal allografts.
Slegers TP; van der Gaag R; van Rooijen N; van Rij G; Streilein JW
Curr Eye Res; 2003 Feb; 26(2):73-9. PubMed ID: 12815525
[TBL] [Abstract][Full Text] [Related]
79. OVA-specific CD8+ T cells do not express granzyme B during anterior chamber associated immune deviation.
Ren Y; Yang P; Li B; Gao Y; Zhou H; Huang X; Zhu L; Kijlstra A
Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1315-21. PubMed ID: 16538449
[TBL] [Abstract][Full Text] [Related]
80. Induction of delayed hypersensitivity to alloantigens coinjected with Langerhans cells into the anterior chamber of the eye. Abrogation of anterior chamber-associated immune deviation.
Williamson JS; Streilein JW
Transplantation; 1989 Mar; 47(3):519-24. PubMed ID: 2493700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
